Annual SG&A:
$63.53M+$8.49M(+15.43%)Summary
- As of today, KYMR annual SG&A is $63.53 million, with the most recent change of +$8.49 million (+15.43%) on December 31, 2024.
- During the last 3 years, KYMR annual SG&A has risen by +$27.19 million (+74.81%).
- KYMR annual SG&A is now at all-time high.
Performance
KYMR SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$17.64M(-100.00%)Summary
- As of today, KYMR quarterly SG&A is $0.00, with the most recent change of -$17.64 million (-100.00%) on September 30, 2025.
- Over the past year, KYMR quarterly SG&A has dropped by -$15.46 million (-100.00%).
- KYMR quarterly SG&A is now -100.00% below its all-time high of $17.64 million, reached on June 30, 2025.
Performance
KYMR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$3.45B-$295.12M(-9.35%)Summary
- As of today, KYMR TTM SG&A is -$3.45 billion, with the most recent change of -$295.12 million (-9.35%) on September 30, 2025.
- Over the past year, KYMR TTM SG&A has dropped by -$3.51 billion (-5717.19%).
- KYMR TTM SG&A is now -4413.17% below its all-time high of -$76.46 million.
Performance
KYMR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
KYMR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +15.4% | -100.0% | -5717.2% |
| 3Y3 Years | +74.8% | -100.0% | -7953.3% |
| 5Y5 Years | +696.1% | -100.0% | -10000.0% |
KYMR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +74.8% | -100.0% | at low | -200.2% | at low |
| 5Y | 5-Year | at high | +696.1% | -100.0% | at low | -1047.8% | at low |
| All-Time | All-Time | at high | +1584.4% | -100.0% | at low | -4413.2% | at low |
KYMR Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $50.25M(-23.5%) |
| Jun 2025 | - | $17.64M(+8.4%) | $65.70M(+0.4%) |
| Mar 2025 | - | $16.27M(-0.4%) | $65.43M(+3.0%) |
| Dec 2024 | $63.53M(+15.4%) | $16.33M(+5.7%) | $63.53M(+3.4%) |
| Sep 2024 | - | $15.46M(-11.0%) | $61.43M(+2.2%) |
| Jun 2024 | - | $17.37M(+20.9%) | $60.09M(+5.7%) |
| Mar 2024 | - | $14.37M(+1.0%) | $56.85M(+3.3%) |
| Dec 2023 | $55.04M(+25.6%) | $14.23M(+0.8%) | $55.04M(+4.9%) |
| Sep 2023 | - | $14.12M(-0.1%) | $52.45M(+7.3%) |
| Jun 2023 | - | $14.13M(+12.4%) | $48.89M(+6.8%) |
| Mar 2023 | - | $12.56M(+8.0%) | $45.79M(+4.5%) |
| Dec 2022 | $43.83M | $11.64M(+10.2%) | $43.84M(-0.2%) |
| Sep 2022 | - | $10.56M(-4.3%) | $43.94M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $11.03M(+4.0%) | $44.05M(+7.3%) |
| Mar 2022 | - | $10.61M(-9.6%) | $41.05M(+12.9%) |
| Dec 2021 | $36.34M(+99.3%) | $11.74M(+10.1%) | $36.34M(+22.0%) |
| Sep 2021 | - | $10.67M(+32.9%) | $29.78M(+14.8%) |
| Jun 2021 | - | $8.03M(+35.9%) | $25.95M(+20.2%) |
| Mar 2021 | - | $5.91M(+14.2%) | $21.58M(+18.4%) |
| Dec 2020 | $18.23M(+128.5%) | $5.17M(-24.3%) | $18.23M(+17.0%) |
| Sep 2020 | - | $6.84M(+86.8%) | $15.59M(+52.1%) |
| Jun 2020 | - | $3.66M(+43.1%) | $10.25M(+55.6%) |
| Mar 2020 | - | $2.56M(+1.1%) | $6.59M(+63.5%) |
| Dec 2019 | $7.98M(+111.6%) | $2.53M(+68.6%) | $4.03M(+168.6%) |
| Sep 2019 | - | $1.50M | $1.50M |
| Dec 2018 | $3.77M | - | - |
FAQ
- What is Kymera Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. annual SG&A year-on-year change?
- What is Kymera Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Kymera Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. TTM SG&A year-on-year change?
What is Kymera Therapeutics, Inc. annual SG&A?
The current annual SG&A of KYMR is $63.53M
What is the all-time high annual SG&A for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high annual SG&A is $63.53M
What is Kymera Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, KYMR annual SG&A has changed by +$8.49M (+15.43%)
What is Kymera Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of KYMR is $0.00
What is the all-time high quarterly SG&A for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high quarterly SG&A is $17.64M
What is Kymera Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, KYMR quarterly SG&A has changed by -$15.46M (-100.00%)
What is Kymera Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of KYMR is -$3.45B
What is the all-time high TTM SG&A for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high TTM SG&A is -$76.46M
What is Kymera Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, KYMR TTM SG&A has changed by -$3.51B (-5717.19%)